Abstract
Mitochondrial dysfunction is a hallmark of common cardiovascular disorders, including ischemia–reperfusion injury, hypertrophy, heart failure, and diabetes mellitus. While the role of the mitochondrial network in regulating energy production and cell death pathways is well established, its active control of other critical cellular functions, including excitation–contraction coupling and excitability, is less understood. The purpose of this focused review article is to highlight the growing mechanistic link between mitochondrial dysfunction and arrhythmogenesis. The goal is not to provide a comprehensive listing of all factors by which mitochondrial bioenergetics and altered cellular redox status affect ion channel function but rather to focus on one central mechanism of arrhythmogenesis which arises from a mitochondrial origin. In doing so, we discuss the role of mitochondrial targets for suppressing arrhythmias through this mechanism.
Similar content being viewed by others
Abbreviations
- I/R:
-
Ischemia–reperfusion injury
- LVH:
-
Left ventricular hypertrophy
- HF:
-
Heart failure
- MI:
-
Myocardial infarction
- AP:
-
Action potential
- APD:
-
Action potential duration
- ETC:
-
Electron transport chain
- ATP:
-
Adenine triphosphate
- DYm:
-
Mitochondrial membrane potential
- ROS:
-
Reactive oxygen species
- H2O2 :
-
Hydrogen peroxide
- O2 − :
-
Superoxide anion
- RIRR:
-
ROS-induced ROS release
- OS:
-
Oxidative stress
- sarcKATP :
-
Sarcolemmal ATP-sensitive potassium channels
- mPTP:
-
Mitochondrial permeability transition pore
- CsA:
-
Cyclosporine-A
- IMAC:
-
Inner membrane anion channel
- 4′-Cl-DZP:
-
4′-Chlorodiazepam (IMAC blocker)
- mBzR:
-
Mitochondrial benzodiazepine receptor
References
O'Rourke, B. (2007). Mitochondrial ion channels. Annual Review of Physiology, 69, 19–49.
Liu, M., Liu, H., & Dudley, S. C., Jr. (2010). Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circulation Research, 107(8), 967–974.
Wang, J., Wang, H., Zhang, Y., Gao, H., Nattel, S., & Wang, Z. (2004). Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator. The Journal of Biological Chemistry, 279(14), 13289–13292.
Weiss, J. N., Lamp, S. T., & Shine, K. I. (1989). Cellular K+ loss and anion efflux during myocardial ischemia and metabolic inhibition. The American Journal of Physiology, 256(4 Pt 2), H1165–H1175.
Terentyev, D., Gyorke, I., Belevych, A. E., Terentyeva, R., Sridhar, A., Nishijima, Y., et al. (2008). Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure. Circulation Research, 103(12), 1466–1472.
Smyth, J. W., Hong, T. T., Gao, D., Vogan, J. M., Jensen, B. C., Fong, T. S., et al. (2010). Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. The Journal of Clinical Investigation, 120(1), 266–279.
Belevych, A. E., Terentyev, D., Viatchenko-Karpinski, S., Terentyeva, R., Sridhar, A., Nishijima, Y., et al. (2009). Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death. Cardiovascular Research, 84(3), 387–395.
Aggarwal, N. T., & Makielski, J. C. (2013). Redox control of cardiac excitability. Antioxidants & Redox Signaling, 18(4), 432–468.
Zorov, D. B., Filburn, C. R., Klotz, L. O., Zweier, J. L., & Sollott, S. J. (2000). Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. The Journal of Experimental Medicine, 192(7), 1001–1014.
Yang, L., Korge, P., Weiss, J. N., & Qu, Z. (2010). Mitochondrial oscillations and waves in cardiac myocytes: insights from computational models. Biophysical Journal, 98(8), 1428–1438.
Aon, M. A., Cortassa, S., Marban, E., & O'Rourke, B. (2003). Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. The Journal of Biological Chemistry, 278(45), 44735–44744.
Aon, M. A., Cortassa, S., Akar, F. G., Brown, D. A., Zhou, L., & O'Rourke, B. (2009). From mitochondrial dynamics to arrhythmias. The International Journal of Biochemistry & Cell Biology, 41(10), 1940–1948.
Aon, M. A., Cortassa, S., Akar, F. G., & O'Rourke, B. (2006). Mitochondrial criticality: a new concept at the turning point of life or death. Biochimica et Biophysica Acta, 1762(2), 232–240.
O'Rourke, B., Ramza, B. M., & Marban, E. (1994). Oscillations of membrane current and excitability driven by metabolic oscillations in heart cells. Science, 265(5174), 962–966.
Akar, F. G., Aon, M. A., Tomaselli, G. F., & O'Rourke, B. (2005). The mitochondrial origin of postischemic arrhythmias. The Journal of Clinical Investigation, 115(12), 3527–3535.
Akar, F. G., & O'Rourke, B. (2011). Mitochondria are sources of metabolic sink and arrhythmias. Pharmacology and Therapeutics, 131(3), 287–294.
del Valle, H. F., Lascano, E. C., Negroni, J. A., & Crottogini, A. J. (2001). Glibenclamide effects on reperfusion-induced malignant arrhythmias and left ventricular mechanical recovery from stunning in conscious sheep. Cardiovascular Research, 50(3), 474–485.
Csordas, G., Varnai, P., Golenar, T., Sheu, S. S., & Hajnoczky, G. (2012). Calcium transport across the inner mitochondrial membrane: molecular mechanisms and pharmacology. Molecular and Cellular Endocrinology, 353(1–2), 109–113.
Beutner, G., Sharma, V. K., Lin, L., Ryu, S. Y., Dirksen, R. T., & Sheu, S. S. (2005). Type 1 ryanodine receptor in cardiac mitochondria: transducer of excitation-metabolism coupling. Biochimica et Biophysica Acta, 1717(1), 1–10.
Laskowski, K. R., & Russell, R. R., 3rd. (2008). Uncoupling proteins in heart failure. Current Heart Failure Reports, 5(2), 75–79.
Brady, N. R., Hamacher-Brady, A., Westerhoff, H. V., & Gottlieb, R. A. (2006). A wave of reactive oxygen species (ROS)-induced ROS release in a sea of excitable mitochondria. Antioxidants & Redox Signaling, 8(9–10), 1651–1665.
Peixoto, P. M., Ryu, S. Y., & Kinnally, K. W. (2010). Mitochondrial ion channels as therapeutic targets. FEBS Letters, 584(10), 2142–2152.
Piot, C., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., et al. (2008). Effect of cyclosporine on reperfusion injury in acute myocardial infarction. The New England Journal of Medicine, 359(5), 473–481.
Dow, J., Bhandari, A., & Kloner, R. A. (2009). The mechanism by which ischemic postconditioning reduces reperfusion arrhythmias in rats remains elusive. Journal of Cardiovascular Pharmacology and Therapeutics, 14(2), 99–103.
Brown, D. A., Aon, M. A., Akar, F. G., Liu, T., Sorarrain, N., & O'Rourke, B. (2008). Effects of 4′-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart. Cardiovascular Research, 79(1), 141–149.
Halestrap, A. P. (2010). A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochemical Society Transactions, 38(4), 841–860.
Garlid, K. D., Beavis, A. D., & Ratkje, S. K. (1989). On the nature of ion leaks in energy-transducing membranes. Biochimica et Biophysica Acta, 976(2–3), 109–120.
Lyon, A. R., Joudrey, P. J., Jin, D., Nass, R. D., Aon, M. A., O'Rourke, B., et al. (2010). Optical imaging of mitochondrial function uncovers actively propagating waves of mitochondrial membrane potential collapse across intact heart. Journal of Molecular and Cellular Cardiology, 49, 565–575.
Slodzinski, M. K., Aon, M. A., & O'Rourke, B. (2008). Glutathione oxidation as a trigger of mitochondrial depolarization and oscillation in intact hearts. Journal of Molecular and Cellular Cardiology, 45(5), 650–660.
Matsumoto-Ida, M., Akao, M., Takeda, T., Kato, M., & Kita, T. (2006). Real-time 2-photon imaging of mitochondrial function in perfused rat hearts subjected to ischemia/reperfusion. Circulation, 114(14), 1497–1503.
Biary, N., Xie, C., Kauffman, J., & Akar, F. G. (2011). Biophysical properties and functional consequences of reactive oxygen species (ROS)-induced ROS release in intact myocardium. The Journal of Physiology, 589(Pt 21), 5167–5179.
Webster, K. A. (2007). Programmed death as a therapeutic target to reduce myocardial infarction. Trends in Pharmacological Sciences, 28(9), 492–499.
Halestrap, A. P. (2006). Calcium, mitochondria and reperfusion injury: a pore way to die. Biochemical Society Transactions, 34(Pt 2), 232–237.
Leong, H. S., Brownsey, R. W., Kulpa, J. E., & Allard, M. F. (2003). Glycolysis and pyruvate oxidation in cardiac hypertrophy—why so unbalanced? Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology, 135(4), 499–513.
Jin, H., Nass, R. D., Joudrey, P. J., Lyon, A. R., Chemaly, E. R., Rapti, K., et al. (2010). Altered spatiotemporal dynamics of the mitochondrial membrane potential in the hypertrophied heart. Biophysical Journal, 98(10), 2063–2071.
Nagendran, J., Gurtu, V., Fu, D. Z., Dyck, J. R., Haromy, A., Ross, D. B., et al. (2008). A dynamic and chamber-specific mitochondrial remodeling in right ventricular hypertrophy can be therapeutically targeted. The Journal of Thoracic and Cardiovascular Surgery, 136(1), 168–178. 78 e1–3.
Sharma, A. K., Dhingra, S., Khaper, N., & Singal, P. K. (2007). Activation of apoptotic processes during transition from hypertrophy to heart failure in guinea pigs. American Journal of Physiology, 293(3), H1384–H1390.
Matas, J., Young, N. T., Bourcier-Lucas, C., Ascah, A., Marcil, M., Deschepper, C. F., et al. (2009). Increased expression and intramitochondrial translocation of cyclophilin-D associates with increased vulnerability of the permeability transition pore to stress-induced opening during compensated ventricular hypertrophy. Journal of Molecular and Cellular Cardiology, 46(3), 420–430.
Garciarena, C. D., Caldiz, C. I., Portiansky, E. L., de Cingolani GE, C., & Ennis, I. L. (2009). Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart. Journal of Applied Physiology, 106(4), 1325–1331.
Turrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. The Journal of Physiology, 552(Pt 2), 335–344.
Chen, F., De Diego, C., Xie, L. H., Yang, J. H., Klitzner, T. S., & Weiss, J. N. (2007). Effects of metabolic inhibition on conduction, Ca transients, and arrhythmia vulnerability in embryonic mouse hearts. American Journal of Physiology, 293(4), H2472–H2478.
Michels, G., Khan, I. F., Endres-Becker, J., Rottlaender, D., Herzig, S., Ruhparwar, A., et al. (2009). Regulation of the human cardiac mitochondrial Ca2+ uptake by 2 different voltage-gated Ca2+ channels. Circulation, 119(18), 2435–2443.
Ozcan C, Palmeri M, Horvath TL, Russell KS, Russell RR. (2013). Role of uncoupling protein 3 in ischemia-reperfusion injury, arrhythmias and preconditioning. American Journal of Physiology, 304(9), H1192–1200.
Brennan, J. P., Southworth, R., Medina, R. A., Davidson, S. M., Duchen, M. R., & Shattock, M. J. (2006). Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovascular Research, 72(2), 313–321.
Hatcher, A. S., Alderson, J. M., & Clements-Jewery, H. (2011). Mitochondrial uncoupling agents trigger ventricular fibrillation in isolated rat hearts. Journal of Cardiovascular Pharmacology, 57(4), 439–446.
Smith, R. M., Velamakanni, S. S., & Tolkacheva, E. G. (2012). Interventricular heterogeneity as a substrate for arrhythmogenesis of decoupled mitochondria during ischemia in the whole heart. American Journal of Physiology, 303(2), H224–H233.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akar, F.G. Mitochondrial targets for arrhythmia suppression: is there a role for pharmacological intervention?. J Interv Card Electrophysiol 37, 249–258 (2013). https://doi.org/10.1007/s10840-013-9809-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-013-9809-3